Rationale and study design of an early care, therapeutic education, and psychological intervention program for the management of post-intensive care syndrome and chronic pain after COVID-19 infection (PAIN-COVID): study protocol for a randomized controlled trial

Antonio Ojeda, Andrea Calvo, Tomas Cuñat, Ricard Mellado Artigas, Oscar Comino-Trinidad, Jorge Aliaga, Marilyn Arias, Maribel Ahuir, Carlos Ferrando, Christian Dürsteler, Antonio Ojeda, Andrea Calvo, Tomas Cuñat, Ricard Mellado Artigas, Oscar Comino-Trinidad, Jorge Aliaga, Marilyn Arias, Maribel Ahuir, Carlos Ferrando, Christian Dürsteler

Abstract

Background: Critically ill patients with COVID-19 are an especially susceptible population to develop post-intensive care syndrome (PICS) due to acute respiratory distress syndrome (ARDS). Patients can suffer acute severe pain and may have long-term mental, cognitive, and functional health deterioration after discharge. However, few controlled trials are evaluating interventions for the prevention and treatment of PICS. The study hypothesis is that a specific care program based on early therapeutic education and psychological intervention improves the quality of life of patients at risk of developing PICS and chronic pain after COVID-19. The primary objective is to determine whether the program is superior to standard-of-care on health-related quality of life at 6 months after hospital discharge. The secondary objectives are to determine whether the intervention is superior to standard-of-care on health-related quality of life, incidence of chronic pain and degree of functional limitation, incidence of anxiety, depression, and post-traumatic stress syndrome at 3 and 6 months after hospital discharge.

Methods: The PAINCOVID trial is a unicentric randomized, controlled, patient-blinded superiority trial with two parallel groups. The primary endpoint is the health-related quality of life at 6 months after hospital discharge, and randomization will be performed with a 1:1 allocation ratio. This paper details the methodology and statistical analysis plan of the trial and was submitted before outcome data were available. The estimated sample size is 84 patients, 42 for each arm. Assuming a lost to follow-up rate of 20%, a sample size of 102 patients is necessary (51 for each arm).

Discussion: This is the first randomized clinical trial assessing the effectiveness of an early care therapeutic education, and psychological intervention program for the management of PICS and chronic pain after COVID-19. The intervention will serve as proof of the need to implement early care programs at an early stage, having an incalculable impact given the current scenario of the pandemic.

Trial registration: This study is being conducted in accordance with the tenets of the Helsinki Declaration and has been approved by the authors' institutional review board Comité Ético de Investigación Clínica del Hospital Clínic de Barcelona (approval number: HCB/2020/0549) and was registered on May 9, 2020, at clinicaltrials.gov ( NCT04394169 ).

Keywords: COVID-19; Chronic pain; Critical illness; Post ICU syndrome; Protocol; Randomized controlled trial.

Conflict of interest statement

The authors declare no conflict of interest in relation to this manuscript.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Summary of patient flow diagram
Fig. 2
Fig. 2
Schedule of enrolment interventions and assessment, SPIRIT 2013

References

    1. COVID-19 Map - Johns Hopkins Coronavirus Resource Center [Internet]. [cited 2020 Jul 21]. Available from:
    1. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei CL, Hui DSC, du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032.
    1. Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldecoa C, Bordell A, et al. Características, evolución clínica y factores asociados a la mortalidad en UCI de los pacientes críticos infectados por SARS-CoV-2 en España: estudio prospectivo, de cohorte y multi-céntrico. Revista Española de Anestesiología y Reanimación [Internet]. 2020 Jul [cited 2020 Jul 27];S0034935620301870. Available from:
    1. Amrein K, Papinutti A, Mathew E, Vila G, Parekh D. Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa. Endocrine Connections [Internet]. 2018 Dec [cited 2020 May 28];R304–15. Available from:
    1. Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. NLM (Medline): British journal of anaesthesia; 2020.
    1. Elliott D, Davidson JE, Harvey MA, Bemis-Dougherty A, Hopkins RO, Iwashyna TJ, Wagner J, Weinert C, Wunsch H, Bienvenu OJ, Black G, Brady S, Brodsky MB, Deutschman C, Doepp D, Flatley C, Fosnight S, Gittler M, Gomez BT, Hyzy R, Louis D, Mandel R, Maxwell C, Muldoon SR, Perme CS, Reilly C, Robinson MR, Rubin E, Schmidt DM, Schuller J, Scruth E, Siegal E, Spill GR, Sprenger S, Straumanis JP, Sutton P, Swoboda SM, Twaddle ML, Needham DM. Exploring the scope of post–intensive care syndrome therapy and care. Critical Care Medicine. 2014;42(12):2518–2526. doi: 10.1097/CCM.0000000000000525.
    1. Inoue S, Hatakeyama J, Kondo Y, Hifumi T, Sakuramoto H, Kawasaki T, Taito S, Nakamura K, Unoki T, Kawai Y, Kenmotsu Y, Saito M, Yamakawa K, Nishida O. Post-intensive care syndrome: its pathophysiology, prevention, and future directions. Acute Medicine & Surgery. 2019;6(3):233–246. doi: 10.1002/ams2.415.
    1. Vlake JH, Van Genderen ME, Schut A, Verkade M, Wils EJ, Gommers D, et al. Patients suffering from psychological impairments following critical illness are in need of information. Journal of Intensive Care. 2020;8(1):6. doi: 10.1186/s40560-019-0422-0.
    1. Lee M, Kang J, Jeong YJ. Risk factors for post–intensive care syndrome: a systematic review and meta-analysis. Australian Critical Care. 2020;33:287–294. doi: 10.1016/j.aucc.2019.10.004.
    1. Kredentser MS, Blouw M, Marten N, Sareen J, Joseph Bienvenu O, Ryu J, et al. Preventing posttraumatic stress in ICU survivors: a single-center pilot randomized controlled trial of ICU diaries and psychoeducation. Critical Care Medicine. 2018;46(12):1914–1922. doi: 10.1097/CCM.0000000000003367.
    1. Li H, Xue Q, Xu X. Involvement of the nervous system in SARS-CoV-2 infection. Neurotox Res. 2020:1–7 Available from: . [cited 2020 Jul 28].
    1. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurology. 2020:S1474442220302210 Available from: . [cited 2020 Jul 28].
    1. Vittori A, Lerman J, Cascella M, Gomez-Morad AD, Marchetti G, Marinangeli F, et al. COVID-19 Pandemic ARDS survivors: pain after the storm? Anesthesia and analgesia. 2020;27:131(1).
    1. Busico M, das Neves A, Carini F, Pedace M, Villalba D, Foster C, et al. Follow-up program after intensive care unit discharge. Medicina Intensiva. 2019;43(4):243–254. doi: 10.1016/j.medin.2018.12.005.
    1. Global Surveillance for human infection with coronavirus disease (COVID-19) [Internet]. [cited 2020 Jul 27]. Available from:
    1. SECPAL [Internet]. [cited 2020 Jul 27]. Available from:
    1. Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. General Hospital Psychiatry. 2003;25(4):277–283. doi: 10.1016/S0163-8343(03)00043-4.
    1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
    1. Creavin ST, Wisniewski S, Noel-Storr AH, Trevelyan CM, Hampton T, Rayment D, et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Vol. 2016. John Wiley and Sons Ltd: Cochrane Database of Systematic Reviews; 2016.
    1. Badia X, Roset M, Montserrat S, Herdman M, Segura A. The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Medicina clinica. 1999;112 Suppl 1:79–85.
    1. Brief Pain Inventory (BPI) | MD Anderson Cancer Center [Internet]. [cited 2020 Jul 27]. Available from:
    1. Gewandter JS, Dworkin RH, Turk DC, Farrar JT, Fillingim RB, Gilron I, et al. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations. Pain. 2015;156:1184–1197. doi: 10.1097/j.pain.0000000000000191.
    1. Darnall BD, Sturgeon JA, Cook KF, Taub CJ, Roy A, Burns JW, Sullivan M, Mackey SC. Development and validation of a daily pain catastrophizing scale. Journal of Pain. 2017;18(9):1139–1149. doi: 10.1016/j.jpain.2017.05.003.
    1. Perez C, Galvez R, Huelbes S, Insausti J, Bouhassira D, Diaz S, Rejas J. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health and Quality of Life Outcomes. 2007;5(1):66. doi: 10.1186/1477-7525-5-66.
    1. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. Journal of Psychosomatic Research. 2002;52(2):69–77. doi: 10.1016/S0022-3999(01)00296-3.
    1. Ruggiero KJ, Del Ben K, Scotti JR, Rabalais AE. Psychometric properties of the PTSD checklist - civilian version. Journal of Traumatic Stress. 2003;16(5):495–502. doi: 10.1023/A:1025714729117.
    1. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD checklist (PCL) Behaviour Research and Therapy. 1996;34(8):669–673. doi: 10.1016/0005-7967(96)00033-2.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera